Evidence map›Paper›PMID 37405935›Full record

ArticleCancer communications (London, England)2023

Clinical utility of circulating tumor DNA sequencing with a large panel in patients with advanced soft-tissue sarcomas.

Julie Blanchi, Sofiane Taleb, Arnaud Bayle, Benjamin Verret, Maud Toulmonde, Mariella Spalato-Ceruso, Paul Dubos, Yech'an Laizet, Melissa Alame, Emmanuel Khalifa and 1 more

Abstract readLetter
In one paragraph

Article in Cancer communications (London, England), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Julie Blanchi *INSERM, Unité 1312, SARCOTARGET team, Bordeaux, France.
Sofiane Taleb *Drug Developpement Department, Gustave Roussy, Villejuif, France.
Arnaud BayleDrug Developpement Department, Gustave Roussy, Villejuif, France.
Benjamin VerretDepartment of Medicine, Gustave Roussy, Villejuif, France.
Maud ToulmondeSarcoma Unit, Institut Bergonié, Bordeaux, France.
Mariella Spalato-CerusoINSERM, Unité 1312, SARCOTARGET team, Bordeaux, France.
Paul DubosSarcoma Unit, Institut Bergonié, Bordeaux, France.
Yech'an LaizetSarcoma Unit, Institut Bergonié, Bordeaux, France.
Melissa AlameDepartment of BioPathology, Institut Bergonié, Bordeaux, France.
Emmanuel KhalifaDepartment of BioPathology, Institut Bergonié, Bordeaux, France.
Antoine ItalianoINSERM, Unité 1312, SARCOTARGET team, Bordeaux, France.ORCID 0000-0002-8540-5351

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Circulating Tumor DNASarcomaSoft Tissue NeoplasmsHumansCirculating Tumor DNA

Identifiers

PMID37405935
PMCPMC10508143

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.